An investigator is studying the clearance of respiratory particles in healthy non-smokers. An aerosol containing radio-labeled particles that are small enough to reach the alveoli is administered to the subjects via a non-rebreather mask. A gamma scanner is then used to evaluate the rate of particle clearance from the lungs. The primary mechanism of particle clearance most likely involves which of the following cell types?
Q2
Thirty minutes after delivery, a 1780-g (3-lb 15-oz) male newborn develops respiratory distress. He was born at 30 weeks' gestation via vaginal delivery. His temperature is 36.8C (98.2F), pulse is 140/min, respirations are 64/min, and blood pressure is 61/32 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 90%. Examination shows pale extremities. Grunting and moderate subcostal retractions are present. Pulmonary examination shows decreased breath sounds bilaterally. Supplemental oxygen is administered. Ten minutes later, his pulse is 148/min and respirations are 66/min. Pulse oximetry on 60% oxygen shows an oxygen saturation of 90%. Which of the following is the most likely diagnosis?
Q3
A P2G1 diabetic woman is at risk of delivering at 29 weeks gestation. Her obstetrician counsels her that there is a risk the baby could have significant pulmonary distress after it is born. However, she states she will give the mother corticosteroids, which will help prevent this from occurring. Additionally, the obstetrician states she will perform a test on the amniotic fluid which will indicate the likelihood of the infant being affected by this syndrome. Which of the following ratios would be most predictive of the infant having pulmonary distress?
Q4
A P1G0 diabetic woman is at risk of delivering at 30 weeks gestation. Her obstetrician counsels her that there is a risk the baby could have significant pulmonary distress after it is born. However, she states she will administer a drug to the mother to help prevent this from occurring. By what action will this drug prevent respiratory distress in the premature infant?
Q5
A 19-year-old primigravid woman at 32 weeks' gestation comes to the physician because of a 2-day history of headache and blurred vision. She has had no prenatal care. She is diagnosed with pre-eclampsia. Amniocentesis shows a lecithin-sphingomyelin ratio of 0.7. If delivery is induced at this time, the newborn is most likely to show which of the following findings?
Q6
Two days after undergoing left hemicolectomy for a colonic mass, a 62-year-old man develops shortness of breath. His temperature is 38.1°C (100.6°F), pulse is 80/min, respirations are 22/min, and blood pressure is 120/78 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 88%. Cardiopulmonary examination shows decreased breath sounds and decreased fremitus at both lung bases. Arterial blood gas analysis on room air shows:
pH 7.35
PaO2 70 mm Hg
PCO2 40 mm Hg
An x-ray of the chest shows a collapse of the bases of both lungs. Which of the following is the most likely underlying mechanism of this patient's hypoxemia?
Q7
A 68-year-old man with both severe COPD (emphysema) and newly diagnosed idiopathic pulmonary fibrosis presents with worsening dyspnea. His pressure-volume curve shows a complex pattern with features of both diseases. Static compliance measured at mid-lung volumes is 120 mL/cm H2O. His pulmonologist must decide on optimal management. Synthesizing the pathophysiology of both conditions, what represents the most significant clinical challenge in managing his combined disease?
Q8
A 42-year-old woman with systemic sclerosis develops both pulmonary fibrosis and chest wall restriction from skin thickening. Her measured total respiratory system compliance is 30 mL/cm H2O. Testing with complete paralysis and positive pressure ventilation shows isolated lung compliance of 50 mL/cm H2O. She is being considered for immunosuppressive therapy versus supportive care. Evaluate which intervention would provide the greatest improvement in her respiratory mechanics.
Q9
A 58-year-old man with end-stage pulmonary fibrosis is being evaluated for lung transplantation. His current static compliance is 25 mL/cm H2O (normal: 200 mL/cm H2O). He also has mild obesity (BMI 32) and ankylosing spondylitis affecting chest wall mobility. Post-transplant, assuming successful bilateral lung transplant with normal donor lungs, what would be the expected change in his total respiratory system compliance?
Q10
A research study compares two patients with different lung pathologies but identical functional residual capacity (FRC) of 3.0 L. Patient A has pulmonary fibrosis with FRC above the steep portion of the compliance curve. Patient B has emphysema with FRC on the flat upper portion of the curve. Both attempt to inhale the same tidal volume. Analyzing their work of breathing, which statement best characterizes the difference?
Surface tension effects on compliance US Medical PG Practice Questions and MCQs
Question 1: An investigator is studying the clearance of respiratory particles in healthy non-smokers. An aerosol containing radio-labeled particles that are small enough to reach the alveoli is administered to the subjects via a non-rebreather mask. A gamma scanner is then used to evaluate the rate of particle clearance from the lungs. The primary mechanism of particle clearance most likely involves which of the following cell types?
A. Goblet cells
B. Macrophages (Correct Answer)
C. Club cells
D. Type I pneumocytes
E. Neutrophils
Explanation: ***Macrophages***
- **Alveolar macrophages** are the primary phagocytic cells in the alveoli responsible for clearing inhaled particles that reach this deepest part of the lung.
- They engulf and digest foreign substances, including pathogens and inert particles, protecting the delicate alveolar structures.
*Goblet cells*
- **Goblet cells** are found in the larger airways (trachea, bronchi), where they produce mucus to trap inhaled particles.
- They are not present in the alveoli, so they cannot clear particles that have reached this region.
*Club cells*
- **Club cells** (formerly Clara cells) are located in the bronchioles and secrete components of the surfactant-like material, but they do not primarily function in particle clearance.
- While they have some protective roles, they are not the main phagocytic cells for alveolar particles.
*Type I pneumocytes*
- **Type I pneumocytes** are flattened, thin cells that form the majority of the alveolar surface and are primarily involved in gas exchange.
- They are not phagocytic and do not play a direct role in clearing inhaled particles.
*Neutrophils*
- **Neutrophils** are acute inflammatory cells primarily involved in combating bacterial infections.
- While they can migrate to the lungs during inflammation, they are not the primary, routine phagocytic cells for clearing inhaled particles in healthy individuals.
Question 2: Thirty minutes after delivery, a 1780-g (3-lb 15-oz) male newborn develops respiratory distress. He was born at 30 weeks' gestation via vaginal delivery. His temperature is 36.8C (98.2F), pulse is 140/min, respirations are 64/min, and blood pressure is 61/32 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 90%. Examination shows pale extremities. Grunting and moderate subcostal retractions are present. Pulmonary examination shows decreased breath sounds bilaterally. Supplemental oxygen is administered. Ten minutes later, his pulse is 148/min and respirations are 66/min. Pulse oximetry on 60% oxygen shows an oxygen saturation of 90%. Which of the following is the most likely diagnosis?
A. Meconium aspiration syndrome
B. Tracheomalacia
C. Tracheoesophageal fistula
D. Neonatal pneumonia
E. Respiratory distress syndrome (Correct Answer)
Explanation: ***Respiratory distress syndrome***
- This premature newborn (30 weeks' gestation, 1780-g) with immediate **respiratory distress**, grunting, retractions, and poor oxygenation despite supplemental oxygen is highly indicative of **respiratory distress syndrome (RDS)** due to surfactant deficiency.
- The **decreased breath sounds bilaterally** are consistent with widespread atelectasis characteristic of RDS.
*Meconium aspiration syndrome*
- This typically occurs in **term or post-term infants** and is unlikely in a 30-week premature infant.
- It usually presents with a history of **meconium-stained amniotic fluid** and chest X-ray findings of patchy infiltrates and hyperinflation.
*Tracheomalacia*
- This condition involves **weakness of the tracheal walls** leading to airway collapse, often presenting with a **barking cough** or **stridor**.
- It does not typically cause the severe, rapidly worsening respiratory distress and diffuse lung findings seen in this case.
*Tracheoesophageal fistula*
- This typically presents with **choking, coughing, and cyanosis during feeding**, due to aspiration of milk into the trachea.
- Respiratory distress in this condition is usually associated with feeding, and there is no mention of feeding issues in this scenario.
*Neonatal pneumonia*
- While possible in a premature infant, pneumonia symptoms often include **fever** and specific chest X-ray findings (e.g., infiltrates), which are not emphasized here.
- The rapid onset immediately after birth and progressive nature in a preterm infant strongly point towards a primary respiratory developmental issue like RDS.
Question 3: A P2G1 diabetic woman is at risk of delivering at 29 weeks gestation. Her obstetrician counsels her that there is a risk the baby could have significant pulmonary distress after it is born. However, she states she will give the mother corticosteroids, which will help prevent this from occurring. Additionally, the obstetrician states she will perform a test on the amniotic fluid which will indicate the likelihood of the infant being affected by this syndrome. Which of the following ratios would be most predictive of the infant having pulmonary distress?
A. lecithin:phosphatidylserine < 1.5
B. lecithin:sphingomyelin < 1.5 (Correct Answer)
C. lecithin:sphingomyelin > 1.5
D. lecithin:phosphatidylserine > 3.0
E. lecithin:sphingomyelin > 3.0
Explanation: ***lecithin:sphingomyelin < 1.5***
- A lecithin:sphingomyelin (L:S) ratio less than 2:1 (or 1.5 in some clinical contexts) indicates **fetal lung immaturity** and a **high risk for respiratory distress syndrome (RDS)**.
- The **lecithin level increases** significantly in the amniotic fluid during the third trimester as fetal lungs mature, while **sphingomyelin levels remain relatively constant**.
*lecithin:phosphatidylserine < 1.5*
- While **phosphatidylserine** is a component of surfactant, the **Lecithin:Sphingomyelin (L:S) ratio** is the established and most commonly used marker for fetal lung maturity.
- There is **no widely recognized or clinically validated threshold** for a lecithin:phosphatidylserine ratio in predicting respiratory distress syndrome.
*lecithin:sphingomyelin > 1.5*
- An L:S ratio **greater than 2:1 (or 1.5, in some labs)** generally indicates **fetal lung maturity** and a low risk for respiratory distress syndrome.
- Therefore, this ratio would suggest a **lower likelihood of pulmonary distress**, which contradicts the aim of identifying risk.
*lecithin:phosphatidylserine > 3.0*
- As with an L:S ratio, a higher ratio would generally indicate **lung maturity**, not increased risk for pulmonary distress.
- There is **no clinical standard for lecithin:phosphatidylserine ratio** to assess lung maturity for preventing RDS.
*lecithin:sphingomyelin > 3.0*
- An L:S ratio of **greater than 2:1 (or 3.0 in certain clinical scenarios)** is a strong indicator of **fetal lung maturity**, meaning the risk of respiratory distress syndrome is low.
- The question asks for a ratio that would be **predictive of pulmonary distress**, whereas this ratio indicates the opposite.
Question 4: A P1G0 diabetic woman is at risk of delivering at 30 weeks gestation. Her obstetrician counsels her that there is a risk the baby could have significant pulmonary distress after it is born. However, she states she will administer a drug to the mother to help prevent this from occurring. By what action will this drug prevent respiratory distress in the premature infant?
A. Increasing the secretory product of type II alveolar cells (Correct Answer)
B. Promoting increased surface tension of alveoli
C. Suppressing the neonatal immune system
D. Preventing infection of immature lungs
E. Reducing the secretory product of type II alveolar cells
Explanation: ***Increasing the secretory product of type II alveolar cells***
- The drug administered is likely a **corticosteroid**, which **accelerates fetal lung maturation** by stimulating the production and release of **surfactant** from **type II alveolar cells**.
- **Surfactant** is crucial for reducing surface tension within the alveoli, preventing their collapse and ensuring proper lung function in premature infants.
*Promoting increased surface tension of alveoli*
- This option is incorrect because premature infants suffer from **respiratory distress syndrome (RDS)** due to **insufficient surfactant**, which leads to **high surface tension** and alveolar collapse.
- The goal of treatment is to **reduce surface tension**, not increase it.
*Suppressing the neonatal immune system*
- While corticosteroids do have **immunosuppressive effects**, this is not the primary mechanism by which they prevent **respiratory distress syndrome (RDS)** in premature infants.
- The main goal in this context is lung maturation, not immune modulation.
*Preventing infection of immature lungs*
- Although premature infants are susceptible to infections, the primary purpose of administering corticosteroids in this scenario is to promote **lung maturation** and prevent **respiratory distress syndrome (RDS)** due to **surfactant deficiency**, not to directly prevent infection.
- Antibiotics would be used for infection prevention or treatment.
*Reducing the secretory product of type II alveolar cells*
- This statement is incorrect because the problem in premature infants is a **deficiency of surfactant**, the secretory product of **type II alveolar cells**.
- The treatment aims to **increase** this secretory product to facilitate lung function.
Question 5: A 19-year-old primigravid woman at 32 weeks' gestation comes to the physician because of a 2-day history of headache and blurred vision. She has had no prenatal care. She is diagnosed with pre-eclampsia. Amniocentesis shows a lecithin-sphingomyelin ratio of 0.7. If delivery is induced at this time, the newborn is most likely to show which of the following findings?
A. Increased lung compliance
B. Increased diffusion capacity for carbon monoxide
C. Decreased right ventricular afterload
D. Increased anatomical dead space
E. Decreased functional residual capacity (Correct Answer)
Explanation: ***Decreased functional residual capacity***
- A **lecithin-sphingomyelin (L/S) ratio of 0.7** indicates significant **fetal lung immaturity**, as a ratio less than 1.5-2.0 suggests inadequate surfactant production.
- Inadequate surfactant leads to **alveolar collapse**, reducing the amount of air remaining in the lungs after normal exhalation (**functional residual capacity**), and increasing the risk of **respiratory distress syndrome (RDS)**.
*Increased lung compliance*
- **Lung compliance** is typically **decreased** in newborns with **respiratory distress syndrome** due to collapsed alveoli and stiff lungs from surfactant deficiency.
- Surfactant's role is to reduce surface tension, thereby increasing compliance and preventing alveolar collapse.
*Increased diffusion capacity for carbon monoxide*
- **Diffusion capacity** would be **reduced** due to thickened alveolar membranes, decreased surface area for gas exchange, and increased shunting from atelectasis in immature lungs.
- **Respiratory distress syndrome** impairs gas exchange, including the diffusion of gases like carbon monoxide.
*Decreased right ventricular afterload*
- **Pulmonary hypertension** and **increased right ventricular afterload** are common in newborns with severe respiratory distress due to **hypoxia** and **acidosis** causing pulmonary vasoconstriction.
- This can lead to persistent **fetal circulation** if the pulmonary vascular resistance remains high, resulting in right-to-left shunting.
*Increased anatomical dead space*
- **Anatomical dead space** relates to the conducting airways and is generally **fixed** for a given lung size and development. It is not directly increased by surfactant deficiency.
- The primary issue with **surfactant deficiency** is alveolar collapse, which affects **alveolar dead space** (where gas exchange should occur but doesn't), rather than anatomical dead space.
Question 6: Two days after undergoing left hemicolectomy for a colonic mass, a 62-year-old man develops shortness of breath. His temperature is 38.1°C (100.6°F), pulse is 80/min, respirations are 22/min, and blood pressure is 120/78 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 88%. Cardiopulmonary examination shows decreased breath sounds and decreased fremitus at both lung bases. Arterial blood gas analysis on room air shows:
pH 7.35
PaO2 70 mm Hg
PCO2 40 mm Hg
An x-ray of the chest shows a collapse of the bases of both lungs. Which of the following is the most likely underlying mechanism of this patient's hypoxemia?
A. Increased anatomic dead space
B. Decreased hemoglobin oxygen-binding capacity
C. Decreased chest wall compliance
D. Increased tidal volume
E. Decreased ratio of ventilated alveoli (Correct Answer)
Explanation: ***Decreased ratio of ventilated alveoli***
- The patient's presentation with **shortness of breath**, **decreased breath sounds and fremitus at both lung bases**, and **collapsed lung bases on chest x-ray** points to **atelectasis**.
- **Atelectasis** is a common cause of hypoxemia post-surgery. It occurs when alveoli collapse, leading to areas of the lung that are perfused but not ventilated, resulting in a **ventilation-perfusion (V/Q) mismatch** with a decreased ratio of ventilated alveoli.
*Increased anatomic dead space*
- **Anatomic dead space** refers to the conducting airways where gas exchange does not occur. This value is relatively constant and would not increase significantly to cause such profound hypoxemia in this context.
- Conditions like chronic obstructive pulmonary disease (COPD) can increase dead space, but the patient's acute postoperative presentation and chest X-ray findings do not support this as the primary cause.
*Decreased hemoglobin oxygen-binding capacity*
- This would involve issues like **carbon monoxide poisoning** or specific hemoglobinopathies, which are not indicated by the clinical picture or ABG results (normal pH, PaO2 70 mmHg, PCO2 40 mmHg).
- The PaO2 and SaO2 values indicate a problem with oxygen uptake, not oxygen transport by hemoglobin once bound.
*Decreased chest wall compliance*
- While surgery can cause **pain leading to splinting** and reduced chest wall expansion, which impacts compliance, the primary mechanism of hypoxemia in atelectasis is the **collapse of alveoli**, not solely reduced chest wall movement.
- The **collapsed lung bases** on X-ray directly point to alveolar collapse rather than a general decrease in chest wall compliance as the primary problem.
*Increased tidal volume*
- **Increased tidal volume** would typically improve ventilation and oxygenation, not lead to hypoxemia.
- The patient's **hypoxemia (SaO2 88%, PaO2 70 mmHg)** clearly indicates a problem with oxygen uptake, not an enhancement of respiratory function.
Question 7: A 68-year-old man with both severe COPD (emphysema) and newly diagnosed idiopathic pulmonary fibrosis presents with worsening dyspnea. His pressure-volume curve shows a complex pattern with features of both diseases. Static compliance measured at mid-lung volumes is 120 mL/cm H2O. His pulmonologist must decide on optimal management. Synthesizing the pathophysiology of both conditions, what represents the most significant clinical challenge in managing his combined disease?
A. Pulmonary rehabilitation cannot address the opposing mechanical derangements
B. The increased compliance from emphysema completely negates decreased compliance from fibrosis
C. The opposing effects on compliance create a pseudonormal total respiratory compliance masking disease severity (Correct Answer)
D. Emphysema treatment with bronchodilators will worsen fibrosis progression
E. Oxygen therapy beneficial for COPD will accelerate fibrotic changes
Explanation: ***The opposing effects on compliance create a pseudonormal total respiratory compliance masking disease severity***
- In **Combined Pulmonary Fibrosis and Emphysema (CPFE)**, the **increased lung compliance** from upper-lobe emphysema is offset by the **decreased compliance** from lower-lobe fibrosis.
- This results in a **pseudonormalization** of lung volumes (like FVC and TLC) and compliance measurements, which can lead to a significant **underestimation of disease severity** during clinical assessment.
*Pulmonary rehabilitation cannot address the opposing mechanical derangements*
- While mechanical derangements are complex, **pulmonary rehabilitation** remains a cornerstone of management to improve functional capacity and reduce dyspnea in both conditions.
- The challenge is not that rehabilitation is ineffective, but rather the **physiological monitoring** and objective assessment of progress are hampered by masked lung volumes.
*The increased compliance from emphysema completely negates decreased compliance from fibrosis*
- The two forces do not perfectly negate each other; rather, they coexist to produce a **paradoxical physiological profile** where static measurements appear mid-range while gas exchange is severely impaired.
- Patients often exhibit a **disproportionate reduction in DLCO** (diffusion capacity) despite relatively preserved lung volumes, indicating the negation is only superficial and numerical.
*Emphysema treatment with bronchodilators will worsen fibrosis progression*
- There is no clinical evidence suggesting that **bronchodilators** (beta-agonists or anticholinergics) used for COPD/emphysema accelerate the **pathological scarring** seen in idiopathic pulmonary fibrosis.
- Bronchodilators primarily target **airway smooth muscle** and do not interfere with the fibroblastic pathways driving interstitial lung disease.
*Oxygen therapy beneficial for COPD will accelerate fibrotic changes*
- **Long-term oxygen therapy (LTOT)** is used to treat chronic hypoxemia in both COPD and fibrosis and does not cause or accelerate **lung remodeling** or fibrosis.
- While high concentrations of inspired oxygen (FiO2) can cause **oxidative stress**, the flow rates used for clinical management do not contribute to the progression of pulmonary fibrosis.
Question 8: A 42-year-old woman with systemic sclerosis develops both pulmonary fibrosis and chest wall restriction from skin thickening. Her measured total respiratory system compliance is 30 mL/cm H2O. Testing with complete paralysis and positive pressure ventilation shows isolated lung compliance of 50 mL/cm H2O. She is being considered for immunosuppressive therapy versus supportive care. Evaluate which intervention would provide the greatest improvement in her respiratory mechanics.
A. Supportive care only, as both components contribute equally and irreversibly
B. Combined therapy targeting lung disease with chest wall mobilization (Correct Answer)
C. Aggressive immunosuppression targeting both lung and skin disease
D. Lung-directed therapy only, as it contributes more to total compliance reduction
E. Chest wall-directed physical therapy, as it is the primary limiting factor
Explanation: ***Combined therapy targeting lung disease with chest wall mobilization*** - The total respiratory compliance (Ct) is calculated using the formula **1/Ct = 1/Clung + 1/Cchest wall**; here, 1/30 = 1/50 + 1/Ccw, which calculates the **chest wall compliance** as 75 mL/cm H2O. - Both the lungs (50 mL/cm H2O) and chest wall (75 mL/cm H2O) are significantly below the **normal value of ~200 mL/cm H2O**, meaning both require intervention for meaningful improvement. *Supportive care only, as both components contribute equally and irreversibly* - While both contribute, they are not strictly equal (50 vs 75), and **systemic sclerosis**-associated lung/skin disease may respond to modern therapeutic interventions. - Labeling these as **irreversible** ignores potential benefits from immunosuppression in the active inflammatory stages of **interstitial lung disease**. *Aggressive immunosuppression targeting both lung and skin disease* - While immunosuppression addresses the underlying **pathophysiology**, it may not provide immediate mechanical relief for fixed **chest wall restriction**. - Effective management often requires adding **physical therapy** and mobilization to address the extrinsic mechanical constraint caused by **scleroderma skin thickening**. *Lung-directed therapy only, as it contributes more to total compliance reduction* - Although lung compliance (50) is lower than chest wall compliance (75), ignoring the **chest wall component** neglects a significant portion of the patient's **work of breathing**. - Solely treating the lung disease will not bypass the **extrinsic restriction** imposed by the tight skin and musculoskeletal changes. *Chest wall-directed physical therapy, as it is the primary limiting factor* - The calculations show that **lung compliance** is actually more severely reduced (50) than chest wall compliance (75). - Focusing only on the **chest wall** would leave the primary cause of the **restrictive ventilatory defect** (pulmonary fibrosis) unaddressed.
Question 9: A 58-year-old man with end-stage pulmonary fibrosis is being evaluated for lung transplantation. His current static compliance is 25 mL/cm H2O (normal: 200 mL/cm H2O). He also has mild obesity (BMI 32) and ankylosing spondylitis affecting chest wall mobility. Post-transplant, assuming successful bilateral lung transplant with normal donor lungs, what would be the expected change in his total respiratory system compliance?
A. Improved lung compliance but worsened chest wall compliance from surgery
B. Worse compliance initially due to transplant rejection and denervation
C. Return to completely normal respiratory compliance matching healthy individuals
D. Improved but still reduced compliance due to persistent chest wall restriction (Correct Answer)
E. No significant change because the primary problem is muscular weakness
Explanation: ***Improved but still reduced compliance due to persistent chest wall restriction***
- Total respiratory system compliance follows the formula **1/C_total = 1/C_lungs + 1/C_chest_wall**, meaning the total compliance is limited by the stiffest component.
- While the lung transplant corrects the **pulmonary fibrosis**, the patient's **obesity** and **ankylosing spondylitis** cause extrinsic restriction that maintains a low **chest wall compliance**.
*Improved lung compliance but worsened chest wall compliance from surgery*
- Although surgical trauma can temporarily affect chest wall dynamics, the **ankylosing spondylitis** is the primary chronic factor limiting chest wall expansion here.
- The logic is flawed because the improvement in **lung compliance** from the donor lungs far outweighs any minor surgical stiffness in the long term.
*Worse compliance initially due to transplant rejection and denervation*
- **Denervation** typically leads to loss of the cough reflex but does not significantly alter the mechanical **elasticity** or compliance of the lung tissue itself.
- Acute rejection would decrease compliance, but the question asks for the "expected" outcome of a **successful bilateral transplant**.
*Return to completely normal respiratory compliance matching healthy individuals*
- Total compliance cannot return to normal because the **chest wall** remains stiff due to the patient's underlying skeletal and adipose conditions.
- Even with perfect donor lungs, the **extrapulmonary restriction** means the total system compliance will remain below the normal **200 mL/cm H2O**.
*No significant change because the primary problem is muscular weakness*
- The patient's primary problem in the lungs was **pulmonary fibrosis**, which is a mechanical parenchymal issue, not purely muscular weakness.
- Total compliance will definitely show a **significant increase** from the baseline of 25 mL/cm H2O because the severely stiff fibrotic lungs have been replaced.
Question 10: A research study compares two patients with different lung pathologies but identical functional residual capacity (FRC) of 3.0 L. Patient A has pulmonary fibrosis with FRC above the steep portion of the compliance curve. Patient B has emphysema with FRC on the flat upper portion of the curve. Both attempt to inhale the same tidal volume. Analyzing their work of breathing, which statement best characterizes the difference?
A. Patient B does less work because emphysematous lungs are more compliant
B. Patient A does less work because fibrotic lungs have increased elastic recoil assisting inspiration
C. Patient A does more elastic work; Patient B does more resistive work
D. Patient B does more elastic work due to hyperinflation beyond optimal compliance (Correct Answer)
E. Both do equal work because FRC and tidal volumes are identical
Explanation: ***Patient B does more elastic work due to hyperinflation beyond optimal compliance***
- In **emphysema**, although the lung itself is more compliant, operating on the **flat upper portion** of the pressure-volume curve means that very high pressures are required to increase volume further.
- **Hyperinflation** causes the patient to breathe at high lung volumes where the **chest wall compliance** also decreases, significantly increasing the **elastic work of breathing**.
*Patient B does less work because emphysematous lungs are more compliant*
- While **static compliance** is higher in emphysema, the patient's position on the **asymptotic portion** of the curve makes the **dynamic work** much higher for each breath.
- This ignore the **obstructive pathology** and the mechanical disadvantage of a flattened **diaphragm** that increases total work.
*Patient A does less work because fibrotic lungs have increased elastic recoil assisting inspiration*
- **Increased elastic recoil** in fibrosis actually **opposes inspiration**, making it harder to expand the lungs and increasing work.
- Fibrotic lungs have **decreased compliance** across all volumes, necessitating greater **transpulmonary pressure** for a given tidal volume.
*Patient A does more elastic work; Patient B does more resistive work*
- While Patient B does have increased **resistive work** due to airway collapse, this option ignores the massive increase in **elastic work** occurring at the top of the compliance curve.
- Patient B's work is elevated by both **resistive** and **elastic** components due to the loss of **radial traction** and hyperinflation respectively.
*Both do equal work because FRC and tidal volumes are identical*
- Work of breathing depends on the **slope of the pressure-volume curve** (compliance) at the specific starting volume, not just the volume itself.
- Identical **Functional Residual Capacity (FRC)** does not equate to identical **respiratory mechanics** when the underlying lung pathologies are opposites like fibrosis and emphysema.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
